Urology
Volume 69, Issue 2 , Pages 343-346 , February 2007

Prostate Volume Measured Preoperatively Predicts for Organ-Confined Disease in Men with Clinically Localized Prostate Cancer

  • Fernando J. Bianco Jr

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York
    • F. J. Bianco was supported in part by the American Foundation for Urologic Disease and a training grant (T32-82088) from the National Institutes of Health.
    • Corresponding Author InformationReprint requests: Fernando J. Bianco, Jr., M.D., Department of Urology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 27, New York, NY 10021.
    • ,
  • Kozhaya N. Mallah

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Ruslan Korets

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Hedvig Hricak

      Affiliations

    • Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Peter T. Scardino

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Michael W. Kattan

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York
    • Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio

Received 17 March 2006 ,Accepted 5 October 2006.

References 

  1. Karakiewicz PI, Bazinet M, Aprikian AG, et al. Outcome of sextant biopsy according to gland volume. Urology. 1997;49:55–59
  2. Okihara K, Fritsche HA, Ayala A, et al. Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng/ml. J Urol. 2001;165:1930–1936
  3. Kratochwil VA. [The place of ultrasound diagnosis in urology]. Wien Klin Wochenschr. 1975;87:385–388
  4. Brascho DJ. Radiation therapy planning with ultrasound. Radiol Clin North Am. 1975;13:505–521
  5. Rahmouni A, Yang A, Tempany CM, et al. Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr. 1992;16:935–940
  6. Tewari A, Indudhara R, Shinohara K, et al. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia. J Clin Ultrasound. 1996;24:169–174
  7. Hricak H, Williams RD, Spring DB, et al. Anatomy and pathology of the male pelvis by magnetic resonance imaging. AJR Am J Roentgenol. 1983;141:1101–1110
  8. Babaian RJ, Troncoso P, Bhadkamkar VA, et al. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer. 2001;91:1414–1422
  9. Bianco FJ, Scardino PT, Eastham JA. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“Trifecta”). Urology. 2005;66(suppl 5A):83–94
  10. Bianco FJ, Wood DP, Cher ML, et al. Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancer. Clin Prostate Cancer. 2003;1:242–247
  11. Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer (A multi-institutional update). JAMA. 1997;277:1445–1451
  12. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol. 1991;145:984–987
  13. Seaman EK, Whang IS, Cooner W, et al. Predictive value of prostate-specific antigen density for the presence of micrometastatic carcinoma of the prostate. Urology. 1994;43:645–648
  14. Shinohara K, Wolf JS, Narayan P, et al. Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications. J Urol. 1994;152:120–123
  15. Taneja SS, Hsu EI, Cheli CD, et al. Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis. Urology. 2002;60:10–17
  16. Naya Y, Fritsche HA, Cheli CD, et al. Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer. Urology. 2003;62:1058–1062
  17. Nathan MS, Seenivasagam K, Mei Q, et al. Transrectal ultrasonography: why are estimates of prostate volume and dimension so inaccurate?. Br J Urol. 1996;77:401–407
  18. Sosna J, Rofsky NM, Gaston SM, et al. Determinations of prostate volume at 3-Tesla using an external phased array coil: comparison to pathologic specimens. Acad Radiol. 2003;10:846–853
  19. al-Rimawi M, Griffiths DJ, Boake RC, et al. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostatic volume. Br J Urol. 1994;74:596–600

 This work was supported primarily by the P50-CA92629 SPORE in Prostate Cancer grant from the National Cancer Institute. Additional support came from a gift from the Koch Foundation, Prostate Cancer Foundation, and Leon Lowenstein Foundation.

PII: S0090-4295(06)02343-0

doi: 10.1016/j.urology.2006.10.006

Urology
Volume 69, Issue 2 , Pages 343-346 , February 2007

Article Tools

* Image Usage & Resolution